OBI Pharma, Inc. (TPEX:4174)
Taiwan · Delayed Price · Currency is TWD 48.55
+1.60 (3.41%)
Nov 6, 2026, 1:30 PM CST
OBI Pharma Market Cap
OBI Pharma has a market cap or net worth of 6.39 billion as of November 6, 2026. It is the 20,522nd most valuable company in the world and the 886th biggest in Taiwan. Its market cap has increased by 3.15% in one year.
Market Cap
6.39B
Enterprise Value
7.04B
Revenue
52.20M
Global Rank
Country Rank
#886 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since December 12, 2012, OBI Pharma's market cap has decreased from 16.87B to 6.39B, a decrease of -62.13%. That is a compound annual growth rate of -6.74%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 6.39B | -10.03% |
| Dec 31, 2025 | 7.10B | -53.86% |
| Dec 31, 2024 | 15.39B | -3.28% |
| Dec 29, 2023 | 15.91B | 0.50% |
| Dec 30, 2022 | 15.83B | -30.20% |
| Dec 30, 2021 | 22.68B | -13.48% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| TCM Biotech International | 8.27B |
| PharmaEngine | 7.84B |
| Locus Cell | 7.43B |
| Tanvex BioPharma | 7.13B |
| Acepodia | 7.06B |
| Adimmune | 7.00B |
| Polaris Group | 6.65B |
| Savior Lifetec | 6.27B |